1. Home
  2. NAAS vs NEPH Comparison

NAAS vs NEPH Comparison

Compare NAAS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NaaS Technology Inc.

NAAS

NaaS Technology Inc.

HOLD

Current Price

$3.14

Market Cap

41.7M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.65

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAAS
NEPH
Founded
2019
1997
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7M
40.1M
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
NAAS
NEPH
Price
$3.14
$3.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
23.7K
6.6K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$377.00
Revenue Growth
N/A
32.67
52 Week Low
$1.80
$2.66
52 Week High
$4.54
$6.42

Technical Indicators

Market Signals
Indicator
NAAS
NEPH
Relative Strength Index (RSI) 47.95 49.79
Support Level $2.85 $3.19
Resistance Level $3.25 $3.78
Average True Range (ATR) 0.25 0.24
MACD -0.04 0.00
Stochastic Oscillator 18.19 44.74

Price Performance

Historical Comparison
NAAS
NEPH

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: